Sotorasib in KRAS G12C-mutated non-small cell lung carcinoma

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
PNEUMOLOGIE | 2023年 / 77卷 / 11期
关键词：
D O I：
10.1055/a-2111-0905
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Menschen mit einem fortgeschrittenen nichtkleinzelligen Lungenkarzinom (NSCLC) haben eine schlechte uberlebensprognose. Liegt eine KRAS G12C-Mutation vor, profitieren sie den Ergebnissen der CodeBreak 100-Studie zu Folge von Sotorasib, einem spezifischen und irreversiblen KRAS-Inhibitor. Nun berichten die Studieninitiatorinnen und -initiatoren die 2-Jahres-Datenauswertung bezuglich der Effektivitat, der Sicherheit sowie molekularer Biomarker.
引用
收藏
页码：846 / 846
页数：1
相关论文
共 50 条
  • [1] Sotorasib as First-Line Treatment for Advanced KRAS G12C-Mutated Non-Small Cell Lung Carcinoma: A Case Report
    Iska, Sindu
    Alley, Evan W.
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 183 - 187
  • [2] Sotorasib treatment in KRAS G12C-mutated non-small cell lung cancer: Experience in the Tours university hospital
    Bessy, C.
    Blin, T.
    Pichon, E.
    Marchand-Adam, S.
    Carmier, D.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (01) : 17 - 23
  • [3] Efficacy and safety outcomes in patients receiving sotorasib for advanced KRAS G12C-mutated non-small cell lung cancer
    Milner-Watts, Charlotte
    O'Sullivan, Hazel
    Stewart, James
    Idaikkadar, Praveena
    Tokaca, Nadza
    Davidson, Michael
    Yousaf, Nadia
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary
    Minchom, Anna
    LUNG CANCER, 2023, 178 : S31 - S32
  • [4] Impact of Sotorasib and Adagrasib in KRAS G12C-Mutated NSCLC
    Patel, Sandip P.
    ONCOLOGY-NEW YORK, 2023, 37 (12): : 479 - 479
  • [5] Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer
    Skoulidis, Ferdinandos
    Li, Bob T.
    Hochmair, Maximilian
    Govindan, Ramaswamy
    Vincent, Mark
    van der Wekken, Anthonie J.
    Reguart Aransay, Noemi
    O'Byrne, Kenneth J.
    Girard, Nicolas
    Griesinger, Frank
    Nishio, Makoto
    Haefliger, Simon
    Lindsay, Colin
    Reinmuth, Niels
    Paulus, Astrid
    Papakotoulas, Pavlos
    Kim, Sang-We
    Ferreira, Carlos Gil
    Pasello, Giulia
    Duruisseaux, Michael
    Gennatas, Spyridon
    Dimou, Anastasios
    Mehta, Bhakti
    Kormany, William
    Nduka, Chidozie
    Sylvester, Brooke E.
    Ardito-Abraham, Christine
    Wang, Yang
    de Langen, Adrianus Johannes
    ONCOLOGIST, 2025, 30 (01):
  • [6] COST PER RESPONDER ANALYSIS COMPARING ADAGRASIB AND SOTORASIB IN PATIENTS WITH KRAS G12C-MUTATED PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC)
    Berardi, A.
    Laurie, M.
    Theriou, C.
    Orsini, I
    Bouwmeester, W.
    Gao, S.
    Korytowsky, B.
    VALUE IN HEALTH, 2023, 26 (12) : S119 - S120
  • [7] Sotorasib in KRAS G12C-Mutated Non-Small Cell Lung Cancer: A Multicenter Real-World Experience from the Expanded Access Program in Germany
    Althoff, F. C.
    Stratmann, J. A.
    Doebel, P.
    Rauh, J.
    Trummer, A.
    Huenerlituerkoglu, A. N.
    Frost, N.
    Yildirim, H.
    Christopoulos, P.
    Burkhard, O.
    zum Bueschenfelde, Meyer C.
    von Rose, Becker A.
    Alt, J.
    Aries, S. P.
    Webendoerfer, M.
    Kaldune, S.
    Uhlenbruch, M.
    Tritchkova, G.
    Waller, C. F.
    Rittmeyer, A.
    Hoffknecht, P.
    Braess, J.
    Kopp, H. G.
    Grohe, C.
    Schaefer, M.
    Schumann, C.
    Griesinger, F.
    Kuon, J.
    Sebastian, M.
    Reinmuth, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 145 - 146
  • [8] Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
    Stratmann, Jan A.
    Althoff, Friederike C.
    Doebel, Paula
    Rauh, Jacqueline
    Trummer, Arne
    Huenerlituerkoglu, Ali Nuri
    Frost, Nikolaj
    Yildirim, Huesameddin
    Christopoulos, Petros
    Burkhard, Oswald
    Bueschenfelde, Christian Meyer zum
    von Rose, Aaron Becker
    Alt, Juergen
    Aries, Sven P.
    Webendoerfer, Maximilian
    Kaldune, Stefan
    Uhlenbruch, Mark
    Tritchkova, Guergana
    Waller, Cornelius F.
    Rittmeyer, Achim
    Hoffknecht, Petra
    Braess, Jan
    Koppu, Hans-Georg
    Grohe, Christian
    Schaefer, Monica
    Schumann, Christian
    Griesinger, Frank
    Kuon, Jonas
    Sebastian, Martin
    Reinmuth, Niels
    EUROPEAN JOURNAL OF CANCER, 2024, 201
  • [9] Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary
    de Langen, Adrianus Johannes
    Johnson, Melissa L.
    Mazieres, Julien
    Dingemans, Anne-Marie C.
    Mountzios, Giannis
    Pless, Miklos
    Wolf, Juergen
    Schuler, Martin
    Lena, Herve
    Skoulidis, Ferdinandos
    Yoneshima, Yasuto
    Kim, Sang-We
    Linardou, Helena
    Novello, Silvia
    van der Wekken, Anthonie J.
    Chen, Yuanbin
    Peters, Solange
    Felip, Enriqueta
    Solomon, Benjamin J.
    Ramalingam, Suresh S.
    Dooms, Christophe
    Lindsay, Colin R.
    Ferreira, Carlos Gil
    Blais, Normand
    Obiozor, Cynthia C.
    Wang, Yang
    Mehta, Bhakti
    Varrieur, Tracy
    Ngarmchamnanrith, Gataree
    Stollenwerk, Bjoern
    Waterhouse, David
    Paz-Ares, Luis
    FUTURE ONCOLOGY, 2025,
  • [10] Dissecting the Clinical Characteristics and Treatment Outcomes Correlates of KRAS G12C-Mutated Non-Small Cell Lung Cancer
    Jing, Yawan
    Cheng, Ruixin
    Zeng, Hao
    Huang, Qin
    He, Dongyu
    Sun, Jiayi
    Tian, Panwen
    Li, Yalun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 4507 - 4517
12345